ConforMIS Inc (NASDAQ:CFMS) Has Just Had Its Price Objective Upped by Analysts at Canaccord Genuity to $26.00

Share

Stock Analysis:ConforMIS Inc (NASDAQ:CFMS) Stock Target Increased

In a recent report issued to clients by Canaccord Genuity on Tuesday morning, ConforMIS Inc (NASDAQ:CFMS) had its target PPS boosted to $26.00. The firm now has a solid Buy rating on shares.

From a total of 5 analysts covering ConforMIS Inc (NASDAQ:CFMS) stock, 5 rate it a ”Buy”, 0 a “Sell”, and 0 a ”Hold”. This means that 100% of the ratings are positive. The highest target price is $26 while the lowest target price is $23. The mean of all analyst targets is $25.2 with a 23.18% above today’s ($21.92) stock price. ConforMIS Inc was the topic of 8 analyst reports since July 27, 2015 according to the firm StockzIntelligence Inc. Canaccord Genuity maintained shares on December 8 with “Buy” rating. Oppenheimer maintained CFMS stock in a recent report from August 12 with “Outperform” rating. Finally, JP Morgan initiated the stock with “Overweight” rating in a report issued on a July 27.

The stock increased 2.72% or $0.58 during the last trading session, striking $21.92. Approximately shares of stock traded hands. ConforMIS Inc (NASDAQ:CFMS) has risen 6.00% since November 9, 2015 and is uptrending. It has outperformed by 6.80% the S&P500.

ConforMIS Inc (NASDAQ:CFMS) Has Just Had Its Price Objective Upped by Analysts at Canaccord Genuity to $26.00

ConforMIS, Inc. is a medical technology company. The company has a market cap of $868.80 million. The Firm uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants that are individually sized and shaped, to fit each patient’s anatomy. It currently has negative earnings. It is engaged in offering a line of customized knee implants designed to restore the natural shape of a patient’s knee.

According to Zacks Investment Research, “ConforMIS, Inc. is a medical technology company which develops, manufacture and sells joint replacement implants. The Company’s iFit technology platform consists of iFit Design, iFit Printing and iFit Just-in-Time Delivery. It operates primarily in the United States, Germany and the United Kingdom. The Company serves orthopedic surgeons, hospitals and other medical facilities and patients. ConforMIS, Inc. is based in Bedford, United States.” Get a free copy of the Zacks research report on ConforMIS Inc (CFMS).

COMMENTS: